Methoxy- and Fluoro-chalcone Derivatives Arrest Cell Cycle Progression and Induce Apoptosis in Human Melanoma Cell A375

  • Henmi Kayo
    Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Hiwatashi Yoko
    Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Hikita Eri
    Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Toyama Naoya
    Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Hirano Toshihiko
    Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences

書誌事項

公開日
2009
DOI
  • 10.1248/bpb.32.1109
公開者
公益社団法人 日本薬学会

この論文をさがす

説明

Because of the lack of efficacious treatments for advanced melanoma, new approaches are necessary. Chalcones are contained in fruits and vegetables, and have been suggested to be cancer-preventive. In this study, effects of synthetic chalcone derivatives were investigated especially on the proliferation of human melanoma cells and peripheral blood mononuclear cells (PBMCs). Four out of the 12 synthetic chalcones: 4-trifluoromethyl-4′-methoxychalcone (CH-1), 4-trifluoromethyl-2′-methoxychalcone (CH-3), 3-trifluoromethyl-2′,4′-dimethoxychalcone (CH-4) and 3-trifluoromethyl-4′-methoxychalcone (CH-7) exhibited significant antiproliferative efficacies against the cultured cells of the human melanoma cell line A375. CH-1, CH-3, CH-4, and CH-7 induced cell cycle arrest at the S-G2/M phase within 24 h after the treatment. CH-3, CH-4, and CH-7 significantly activated caspase-3 at 12 h, subsequently induced apoptosis at 72 h. All chalcones inhibited concanavalin A-induced proliferation of PBMCs dose-dependently. Our results suggest that some methoxy- and/or fluoro-chalcones have antitumor efficacy by inducing apoptosis and the cell-cycle arrest.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (18)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ